Uncategorized

Scientists unveil benefits and risks of blockbuster weight-loss drugs – Euronews

  1. Scientists unveil benefits and risks of blockbuster weight-loss drugs  Euronews
  2. Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature.com
  3. Sweeping review suggests weight-loss drugs’ effect on 175 conditions  The Washington Post
  4. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  5. Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind  Livescience.com